AURKB and acute lymphoblastic leukemia: Since the leukemia cell line K-562 was chemosensitive for both aurora kinase inhibitors (GW809897X and GW806742X), we decided to measure the AURKA and AURKB mRNA expression in the ALL patient’s blood cells.